Meldonium or
mildronate, also known as
mildronāts,
Quaterine,
MET-88, and
THP (for its chemical name, see below) is a limited-market cardiac drug manufactured by
Grindeks, a Latvian pharmaceutical company, and distributed online in Eastern European countries as an anti-
ischemia medication.
[not verified in body] It is not approved by the US
Food and Drug Administration, and is not legally available in the United States.
[citation needed] Since January 1st 2016 it has been on the
World Anti-Doping Agency (WADA) list of substances banned from use by athletes;
[1] some athletes are known to have been using it before it was banned.
[2]





